Abstract
The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine administration of a glycoprotein IIb/IIIa inhibitor (GPI) in patients with acute coronary syndrome (ACS).
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 201-213 |
| Numero di pagine | 13 |
| Rivista | JACC: Cardiovascular Interventions |
| Volume | 8 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- GP IIb/IIIa inhibitor
- acute coronary syndrome
- bivalirudin
- heparin
- meta-analysis
Fingerprint
Entra nei temi di ricerca di 'Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver